ArticleOncotarget2019

Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma.

Li Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.